SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,452,000 | -26.7% | 15,706 | -38.4% | 0.15% | -21.0% |
| Q2 2021 | $1,981,000 | +4.3% | 25,485 | 0.0% | 0.20% | -1.0% |
| Q1 2021 | $1,899,000 | -62.0% | 25,485 | -12.9% | 0.20% | -62.0% |
| Q4 2020 | $4,991,000 | +21.4% | 29,276 | 0.0% | 0.52% | +16.9% |
| Q3 2020 | $4,111,000 | -37.9% | 29,276 | -29.1% | 0.44% | -45.4% |
| Q2 2020 | $6,618,000 | +12.8% | 41,276 | -31.2% | 0.81% | +26.5% |
| Q1 2020 | $5,869,000 | -24.2% | 60,002 | 0.0% | 0.64% | -3.3% |
| Q4 2019 | $7,743,000 | +53.4% | 60,002 | -10.4% | 0.66% | +68.3% |
| Q3 2019 | $5,047,000 | -62.3% | 67,002 | -24.0% | 0.39% | -54.7% |
| Q2 2019 | $13,402,000 | +7.2% | 88,201 | -15.9% | 0.87% | +14.8% |
| Q1 2019 | $12,505,000 | +4.8% | 104,917 | -4.1% | 0.76% | +30.3% |
| Q4 2018 | $11,935,000 | -13.1% | 109,362 | +28.7% | 0.58% | +28.8% |
| Q3 2018 | $13,728,000 | +22.2% | 85,000 | 0.0% | 0.45% | +42.3% |
| Q2 2018 | $11,235,000 | – | 85,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |